Shree Veer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.40 M
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.84 M
- Revenue Growth %
- Profit Growth 29.39%
- Ebitda 72.69%
- Net Worth -14.14%
- Total Assets -2.02%
About Shree Veer Pharmaceuticals
Shree Veer Pharmaceuticals Private Limited (SVPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 November 1988 and has a history of 36 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.84 M.
Ramesh Jain, Rajesh Jain, and Manju Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1988PTC033998
-
Company No.
033998
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Nov 1988
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Shree Veer Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Jain
|
Director | 24-May-2013 | Current |
|
Rajesh Jain
|
Director | 24-May-2013 | Current |
|
Manju Jain
|
Additional Director | 07-Sep-2012 | Current |
Financial Performance of Shree Veer Pharmaceuticals.
Shree Veer Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 29.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Veer Pharmaceuticals?
In 2017, Shree Veer Pharmaceuticals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.84 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.14 Cr
- Union Bank Of India Limited : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2009 | Union Bank Of India Limited | ₹0.40 M | Open |
| 17 Jul 2002 | Union Bank Of India | ₹0.40 M | Open |
| 23 Oct 1998 | Union Bank Of India | ₹0.25 M | Open |
| 17 Jul 1997 | Union Bank Of India | ₹0.39 M | Open |
| 17 Apr 1997 | Union Bank Of India | ₹0.39 M | Open |
How Many Employees Work at Shree Veer Pharmaceuticals?
Unlock and access historical data on people associated with Shree Veer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Veer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Veer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
